Is outsourced oligo supply slowing down your gene synthesis work?

Many teams still rely on external vendors for oligo synthesis and accept variable lead times, shipment delays, and limited visibility into quality as just “part of the process.” That model works until it doesn’t: a back-ordered plate, a delayed re-run, or a sensitive sequence you’re not comfortable sending out can put whole projects on hold.

The SYNTAX platform takes a different approach. By bringing enzymatic DNA synthesis into your lab, you can generate high-quality, desalted ssDNA oligos (up to 120nt) overnight. These oligos are ready to drop into your existing gene assembly workflows with no change to your downstream methods just a new level of control at the front end.

During the latest webinar, our team answered key questions:

• How can in-house oligo synthesis eliminate supply uncertainty and give you complete control over your workflow?
• How does SYNTAX compare to external suppliers on performance and quality — across every oligo length?
• How does gene assembly using 60mers vs 120mers SYNTAX oligos compare?
• Can SYNTAX enable the synthesis of poly(A) tails for mRNA applications?

Discover how SYNTAX can give you the ability to respond faster, iterate with confidence, and eliminate uncertainty in your projects.